A Study on the Feasibility of Remimazolam for Day Surgery

A Prospective Randomized Controlled Study on the Feasibility of Remimazolam for Day Surgery under BIS Monitoring

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2600115968

Enrollment

Unknown

Registered

2026-01-04

Start date

2026-01-10

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled for laparoscopic cholecystectomy or laparoscopic hernia repair under general anesthesia at our hospital, with both procedures designated as day-case surgeries.

Interventions

Propofol group:Anesthesia was induced and maintained using a general anesthesia protocol with propofol.

Remimazolam Group:Anesthesia was induced and maintained using the remifentanil group's general anesthesia induction and maintenance protocol.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. ASA physical status II to III.

Exclusion criteria

Exclusion criteria: 1. History of neurological or psychiatric disorders. 2. History of chronic drug abuse or alcohol dependence; 3. Contraindications, intolerance, or allergy to the investigational drugs; 4. Severe hepatic or renal dysfunction; 5. Pregnancy; 6. Body Mass Index (BMI) > 30 kg/m².

Design outcomes

Primary

Measure	Time frame
Time to Eye Opening;	—

Secondary

Measure	Time frame
Length of PACU Stay;MMSE Score;Time to Extubation;	—

Countries

China

Contacts

Public ContactHuang Jianzhong

ZhangZhou Municipal Hospital of Fujian province

zzhjz99@126.com+86 596 208 2987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026